SNCA and Parkinson disease: In preclinical PD models, LRRK2 inhibition has been shown to normalize visual processing deficits in LRRK2-G2019S transgenic fruit flies25 and normalize increases in burst firing of the subthalamic nucleus in AAV α-synuclein rats19.